STAT Plus: Applied Therapeutics’ muted response to a clinical hold speaks volumes
Applied Therapeutics used an SEC filing to disclose that the Food and Drug Administration placed a partial hold on one of its important clinical trials.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario